Synapse - Potent CD8+T-cell proliferation and effector differentiation following subcutaneous (SC) mosunetuzumab administration in patients with untreated, high tumor-burden follicular lymphoma (FL)

Potent CD8+T-cell proliferation and effector differentiation following subcutaneous (SC) mosunetuzumab administration in patients with untreated, high tumor-burden follicular lymphoma (FL) Meeting Abstract

Authors:	Falchi, L.; Lin, Y. H.; Melendez, L.; Ghione, P.; Owens, C.; Hamlin, P. A.; Lue, J. K.; Epstein-Peterson, Z. D.; Kumar, A.; Palomba, M. L.; Torka, P.; Okwali, M.; Ferreira Lopes, A.; Martinova, A.; Wood, L.; Grieve, C.; Ramos Amador, W.; Zelenetz, A. D.; Salles, G.; Vardhana, S. A.
Abstract Title:	Potent CD8+T-cell proliferation and effector differentiation following subcutaneous (SC) mosunetuzumab administration in patients with untreated, high tumor-burden follicular lymphoma (FL)
Meeting Title:	65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	142
Issue:	Suppl. 1
Meeting Dates:	2023 Dec 9-12
Meeting Location:	San Deigo, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2023-11-02
Start Page:	6116
Language:	English
ACCESSION:	WOS:001159900804084
DOI:	10.1182/blood-2023-189638
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos